These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9554653)

  • 1. Long-acting inhaled beta2-agonists in asthma therapy.
    Moore RH; Khan A; Dickey BF
    Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
    Lipworth BJ
    Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
    van der Woude HJ; Aalbers R
    Am J Respir Med; 2002; 1(1):55-74. PubMed ID: 14720076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
    Condemi JJ
    Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH; Walters JA; Gibson MD
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of long-acting beta2-adrenoceptor agonism.
    Lipworth BJ
    Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
    Matthys H
    Respiration; 2001; 68(4):432-7. PubMed ID: 11464097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
    Walters EH; Walters JA; Gibson PW
    Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population.
    Castellsague J; Garcia-Rodríguez LA; Pérez-Gutthann S; Agostinis L; Cattaruzi C; Troncon MG
    Respir Med; 1999 Oct; 93(10):709-14. PubMed ID: 10581659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-acting beta-2-adrenergic agonists in bronchospasm therapy].
    Płusa T
    Pol Merkur Lekarski; 1999 May; 6(35):227-31. PubMed ID: 10437387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.